OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
South Korea
· Delayed Price · Currency is KRW 6,830.00
-10.00 (-0.15%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
| Tearin Blood and Others | 77.76B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Tearin Blood and Others Growth | 11.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nexol Tablet and Others | 2.94B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Nexol Tablet and Others Growth | 36.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| LDPE Scrap and Others | 710.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| LDPE Scrap and Others Growth | 99.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oesu Eye Cleaner and Others | 496.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oesu Eye Cleaner and Others Growth | 144.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Lumeron and Others | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Lumeron and Others Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2013 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2013 - 2019 |
| South Korea | 81.80B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 14.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | 106.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | -84.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|